Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How worthwhile is plasma primidone level measurement?

M J Eadie, R Heazlewood, J H Tyrer

    Clinical and Experimental Neurology
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neurological factors and Cesarean section in Australian women with epilepsy.

    Epilepsy & behavior : E&B·2022
    Same author

    Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register.

    Seizure·2018
    Same author

    Antiepileptic drug polytherapy in pregnant women with epilepsy.

    Acta neurologica Scandinavica·2018
    Same author

    Predicting epileptic seizure control during pregnancy.

    Epilepsy & behavior : E&B·2017
    Same author

    Anti-epileptic drug exposure and risk of foetal death in utero.

    Acta neurologica Scandinavica·2017
    Same author

    Triptan use in Australia 1997-2015: A pharmacoepidemiological study.

    Acta neurologica Scandinavica·2017

    Measuring primidone plasma levels offers limited benefit for epilepsy treatment. Phenobarbitone levels, derived from primidone, better correlate with dosage and are more stable for guiding therapy.

    Area of Science:

    • Clinical Pharmacology
    • Neuropharmacology
    • Epileptology

    Background:

    • Primidone is an anticonvulsant medication used to treat epilepsy.
    • Primidone is metabolized in the body to phenobarbitone, another active anticonvulsant.
    • Understanding the relationship between primidone, its metabolite phenobarbitone, and their plasma levels is crucial for effective epilepsy management.

    Purpose of the Study:

    • To investigate the relationship between simultaneous steady-state plasma levels of primidone and phenobarbitone in patients undergoing primidone therapy.
    • To determine which plasma level measurement (primidone or phenobarbitone) better correlates with primidone dosage.
    • To assess the clinical utility of monitoring primidone plasma levels versus phenobarbitone plasma levels in guiding epilepsy treatment.

    Main Methods:

    Related Experiment Videos

    • Simultaneous steady-state plasma concentrations of primidone and phenobarbitone were measured.
    • The study included 43 patients receiving primidone therapy.
    • Correlations between drug doses and plasma levels, as well as inter-dosage fluctuations, were analyzed.

    Main Results:

    • A linear relationship was observed between individual primidone and phenobarbitone plasma levels.
    • Steady-state plasma phenobarbitone levels showed a stronger correlation with primidone dose compared to primidone plasma levels.
    • Primidone plasma levels exhibited greater inter-dosage fluctuations than phenobarbitone plasma levels.

    Conclusions:

    • Phenobarbitone, as a metabolite of primidone, appears to be eliminated more slowly, leading to more stable plasma levels.
    • Monitoring steady-state plasma phenobarbitone levels may be more informative than monitoring primidone levels for guiding primidone therapy in epilepsy.
    • Concurrent anticonvulsant therapy, age, and sex did not significantly alter these observed relationships.